10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ABBOTT LABORATORIES | ||
Ticker: ABT Fiscal Year: 2016 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2016 10-K (Filed: Feb 17, 2017) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2016 | Dec 31, 2015 | |
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 18,620 | 5,001 |
| Investments, primarily bank time deposits and U.S. treasury bills | 155 | 1,124 |
| Trade receivables, less allowances of - 2016: $250; 2015: $337 | 3,248 | 3,418 |
| Inventories: | ||
| Finished products | 1,624 | 1,744 |
| Work in process | 294 | 316 |
| Materials | 516 | 539 |
| Total inventories | 2,434 | 2,599 |
| Other prepaid expenses and receivables | 1,806 | 1,908 |
| Current assets held for disposition | 513 | 105 |
| Total Current Assets | 26,776 | 14,155 |
| Long-term Investments | 2,947 | 4,041 |
| Property and Equipment, at Cost: | ||
| Land | 408 | 432 |
| Buildings | 2,602 | 2,769 |
| Equipment | 8,394 | 8,254 |
| Construction in progress | 962 | 928 |
| Property and Equipment, at cost | 12,366 | 12,383 |
| Less: accumulated depreciation and amortization | 6,661 | 6,653 |
| Net Property and Equipment | 5,705 | 5,730 |
| Intangible Assets, net of amortization | 4,539 | 5,562 |
| Goodwill | 7,683 | 9,638 |
| Deferred Income Taxes and Other Assets | 2,263 | 2,119 |
| Non-current Assets Held for Disposition | 2,753 | 2 |
| Total Assets | 52,666 | 41,247 |
| Liabilities and Shareholders' Investment | ||
| Current Liabilities: | ||
| Short-term borrowings | 1,322 | 3,127 |
| Trade accounts payable | 1,178 | 1,081 |
| Salaries, wages and commissions | 752 | 746 |
| Other accrued liabilities | 2,581 | 3,043 |
| Dividends payable | 391 | 383 |
| Income taxes payable | 188 | 430 |
| Current portion of long-term debt | 3 | 3 |
| Current liabilities held for disposition | 245 | 373 |
| Total Current Liabilities | 6,660 | 9,186 |
| Long-term Debt | 20,681 | 5,871 |
| Post-employment Obligations and other long-term liabilities | 4,549 | 4,864 |
| Non-current liabilities held for disposition | 59 | |
| Commitments and Contingencies | ||
| Shareholders' Investment: | ||
| Preferred shares, one dollar par value Authorized - 1,000,000 shares, none issued | ||
| Common shares, without par value Authorized - 2,400,000,000 shares Issued at stated capital amount - Shares: 2016: 1,707,475,455; 2015: 1,702,017,390 | 13,027 | 12,734 |
| Common shares held in treasury, at cost - Shares: 2016: 234,606,250; 2015: 229,352,338 | (10,791) | (10,622) |
| Earnings employed in the business | 25,565 | 25,757 |
| Accumulated other comprehensive income (loss) | (7,263) | (6,658) |
| Total Abbott Shareholders' Investment | 20,538 | 21,211 |
| Noncontrolling Interests in Subsidiaries | 179 | 115 |
| Total Shareholders' Investment | 20,717 | 21,326 |
| Total Liabilities and Shareholders' Investment | 52,666 | 41,247 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2016 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |